Your browser doesn't support javascript.
Insomnia episodes, new-onset pharmacological treatments, and other sleep disturbances during the COVID-19 pandemic: a nationwide cross-sectional study in Brazilian health care professionals.
Drager, Luciano F; Pachito, Daniela V; Moreno, Claudia R C; Tavares, Almir R; Conway, Silvia G; Assis, Márcia; Sguillar, Danilo A; Moreira, Gustavo A; Bacelar, Andrea; Genta, Pedro R.
  • Drager LF; Unidade de Hipertensão, Departamento de Clinica Medica, Disciplina de Nefrologia, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil.
  • Pachito DV; Unidade de Hipertensão, Instituto do Coração (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil.
  • Moreno CRC; Núcleo de Avaliação de Tecnologias em Saúde, Hospital Sírio-Libanês, São Paulo, Brazil.
  • Tavares AR; Fundação Getúlio Vargas, São Paulo, Brazil.
  • Conway SG; School of Public Health, University of São Paulo, São Paulo, Brazil.
  • Assis M; Stress Research Institute, Department of Psychology, Stockholm University, Stockholm, Sweden.
  • Sguillar DA; Neurosciences Postgraduate Program, Federal University of Minas Gerais, Belo Horizonte, Brazil.
  • Moreira GA; Akasa-Formação e Conhecimento, São Paulo, Brazil.
  • Bacelar A; Psychiatry Department, University of São Paulo Medical School, São Paulo, Brazil.
  • Genta PR; Clínica do Sono de Curitiba, Hospital São Lucas, Curitiba Paraná, Brazil.
J Clin Sleep Med ; 18(2): 373-382, 2022 02 01.
Article in English | MEDLINE | ID: covidwho-1328232
ABSTRACT
STUDY

OBJECTIVES:

To evaluate the impact of the coronavirus disease 2019 (COVID-19) pandemic on insomnia and other sleep disturbances in health care professionals.

METHODS:

A survey was distributed using social media and organizational emails to Brazilian active health care professionals during the COVID-19 outbreak. We explored potential associated factors including age, sex, occupation, workplace, work hours, income, previous infection with COVID-19, recent/current contact with COVID-19 patients, regional number of incident deaths, anxiety, and burnout. We evaluated new-onset/previous insomnia worsening episodes (primary outcome), new pharmacological treatments, sleep quality, duration, nightmares, and snoring (secondary outcomes).

RESULTS:

A total of 4,384 health professionals from all regions of the country were included in the analysis (44 ± 12 years, 76% females, 53.8% physicians). Overall, 55.7% were assisting patients with COVID-19, and 9.2% had a previous COVID-19 infection. The primary outcome occurred in 32.9% of respondents in parallel to 13% new pharmacological treatments for insomnia. The sleep quality worsened for 61.4%, while 43.5% and 22.8% reported ≥ 1-hour sleep duration reduction and worsening or new-onset nightmares, respectively. Multivariate analyses showed that age (odds ratio [OR] 1.008; 95% confidence interval [CI] 1.001-1.015), females (OR 1.590; 95% CI 1.335-1.900), weight change (decrease OR 1.772; 95% CI 1.453-2.161; increase OR 1.468; 95% CI 1.249-1.728), prevalent anxiety (OR 3.414; 95% CI 2.954-3.948), new-onset burnout (OR 1.761; 95% CI 1.489-2.083), family income reduction > 30% (OR 1.288; 95% CI 1.069-1.553), and assisting patients with COVID-19 (OR 1.275; 95% CI 1.081-1.506) were independently associated with new-onset or worsening of previous insomnia episodes.

CONCLUSIONS:

We observed a huge burden of insomnia episodes and other sleep disturbances in health care professionals during the COVID-19 pandemic. CITATION Drager LF, Pachito DV, Moreno CRC, et al. Insomnia episodes, new-onset pharmacological treatments, and other sleep disturbances during the COVID-19 pandemic a nationwide cross-sectional study in Brazilian health care professionals. J Clin Sleep Med. 2022;18(2)373-382.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Sleep Initiation and Maintenance Disorders Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Female / Humans / Male Country/Region as subject: South America / Brazil Language: English Journal: J Clin Sleep Med Year: 2022 Document Type: Article Affiliation country: Jcsm.9570

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Sleep Initiation and Maintenance Disorders Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Female / Humans / Male Country/Region as subject: South America / Brazil Language: English Journal: J Clin Sleep Med Year: 2022 Document Type: Article Affiliation country: Jcsm.9570